Polymyalgia rheumatica diagnostic study of choice

Jump to navigation Jump to search

Polymyalgia Rheumatica Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polymyalgia rheumatica from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polymyalgia rheumatica diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polymyalgia rheumatica diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polymyalgia rheumatica diagnostic study of choice

CDC on Polymyalgia rheumatica diagnostic study of choice

Polymyalgia rheumatica diagnostic study of choice in the news

Blogs on Polymyalgia rheumatica diagnostic study of choice

Directions to Hospitals Treating Polymyalgia rheumatica

Risk calculators and risk factors for Polymyalgia rheumatica diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

The diagnosis of PMR is mostly clinical and is supported with an elevated ESR and specific findings on ultrasound of the affected joints. The European League Against Rheumatism/American College of Rheumatology collaborative initiative developed a provisional classification criteria for polymyalgia rheumatica. The following criteria are required: age 50 years, bilateral shoulder aching, and abnormal C-reactive protein (CRP and/or erythrocyte sedimentation rate (ESR).

Diagnostic Criteria

  • Shown below is the 2012 provisional classification criteria for polymyalgia rheumatica by the European League Against Rheumatism/American College of Rheumatology collaborative initiative. Each of the findings is given a point, then the total score is calculated by adding all the point. Two scores have been developed depending on whether an ultrasound is performed or not.
  • The following criteria are required in addition to the confirmatory score of the diagnostic criteria:
    • Age 50 years, AND
    • Bilateral shoulder pain, AND
    • Elevated CRP and/or ESR

PMR Diagnostic Criteria Scoring Without Ultrasound

Variable Points
Morning stiffness for 45 minutes 2
Pain or limited range of motion in the hips 1
Absence of rheumatoid factor or anti-citrullinated protein antibody 2
No involvement of other joints 1

PMR Diagnostic Criteria Scoring With Ultrasound

Variable Points
Morning stiffness for 45 minutes 2
Pain or limited range of motion in the hips 1
Absence of rheumatoid factor or anti-citrullinated protein antibody 2
No involvement of other joints 1
At least 1 shoulder with subdeltoid bursitis
AND/OR
biceps tenosynovitis
AND/OR
Glenohumeral synovitis (either posterior or axillary)
AND
at least 1 hip with synovitis and/or trochanteric bursitis
1
Both shoulders with subdeltoid bursitis, biceps tenosynovitis, or glenohumeral synovitis 1

References

Template:WH Template:WS